Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DaVita Inc V.DVA


Primary Symbol: DVA

Healthcare
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.


NYSE:DVA - Post by User

DaVita Inc > Something looks like its brewing....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by DTrader706on Jul 30, 2018 1:04pm
70 Views
Post# 28386011

RE:RE:RE:RE:RE:Something looks like its brewing....

RE:RE:RE:RE:RE:Something looks like its brewing....
I'm sorry, but this is just a OTC cream company, they have nothing else. They lost Canopy and Bobby Orr and that should say a lot. CEO over promises and under delivers each time the said date goes by(look at all the AGMs of past). He and the board are the only ones benefiting here.
Look under the hood and its ugly, way over vauled and worth 0.12 max with what they are doing curently.
There are transdermal companies that are already producing CBD creams. They had thier chance and blew it. Don't try and entice people to waste thier money on this garbage
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities